HC Wainwright Reiterates “Buy” Rating for IceCure Medical (NASDAQ:ICCM)
IceCure Medical (NASDAQ:ICCM – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a report issued on Tuesday, Benzinga reports. They currently have a $3.00 target price on the stock. HC Wainwright’s target price suggests a potential upside of 305.77% from the stock’s current price. Separately, Alliance Global Partners […]
More Stories
BP (NYSE:BP) Upgraded at StockNews.com
StockNews.com upgraded shares of BP (NYSE:BP – Free Report) from a hold rating to a buy rating in a report...
BMO Capital Markets Raises Antero Resources (NYSE:AR) Price Target to $34.00
Antero Resources (NYSE:AR – Free Report) had its price target increased by BMO Capital Markets from $33.00 to $34.00 in...
Boeing (NYSE:BA) Price Target Cut to $195.00
Boeing (NYSE:BA – Free Report) had its target price cut by Deutsche Bank Aktiengesellschaft from $225.00 to $195.00 in a...
AMN Healthcare Services (NYSE:AMN) Earns “Market Outperform” Rating from JMP Securities
JMP Securities restated their market outperform rating on shares of AMN Healthcare Services (NYSE:AMN – Free Report) in a report...
Albany International (NYSE:AIN) PT Lowered to $81.00 at TD Cowen
Albany International (NYSE:AIN – Free Report) had its target price reduced by TD Cowen from $95.00 to $81.00 in a...
Truist Financial Boosts AECOM (NYSE:ACM) Price Target to $119.00
AECOM (NYSE:ACM – Free Report) had its price target lifted by Truist Financial from $108.00 to $119.00 in a research...